|
This 462-page report is designed to give you in-depth analysis of recent legal, regulatory, enforcement and litigation issues and events affecting the industry and how these events impact the present and future.
With this report, you will receive:
- Thorough reporting of these important developments!
- Commentary and analysis from prominent attorneys who offer valuable expertise and insight!
- Practical tips that can give you a heads-up on likely future developments as well as guidance on best practices that can help you face the challenges confronting FDA-regulated industries and their counsel!
Drug & Device Enforcement & Litigation covers a wide range of issues. Some of the topics included in this edition:
- Analyses of major cases
- Medicare Part D
- Whistleblower suits
- Restitution and disgorgement
- Attorney-client privilege
- Preemption
- Clinical trials
- Good manufacturing practices and quality systems
- Counterfeit drugs
Drug & Device Enforcement & Litigation is priced at $599, plus $17.95 in shipping and handling.
You can review this product for 30 days. If you cancel within 30 days of receipt, you will receive a full credit upon return of the product together with a request for cancellation.
Nothing can help drug and device company officials and their counsel deal with these challenging times more than a clear understanding of the latest legal and regulatory developments and their likely effect during the ensuing years. This report will help you gain that understanding and prepare you for future events that will profoundly affect the biotechnology, pharmaceutical and medical device industries.
People who need this report:
- Biotechnology, med-tech and pharmaceutical executives
- Law firms serving these industries
- In-house counsel
- Members of company boards of directors
- Regulatory affairs officers
- Heads of R&D
- Analysts
- Investors
This report can be purchased in print or PDF.
To view sample pages, click here.
|
Print and PDF Version:
|
|
Report-Only Price: $599 + ($17.95 s&h)
|
Order Now
|
|
